Theolytics
Transforming patients’ lives | Through world leading science | With a great team
31 employees · est. 2017 · Oxford, United Kingdom
Genelux is the older company (2001 vs 2017).
Side-by-Side Comparison
| Metric | Genelux | Theolytics |
|---|---|---|
| Founded | ||
| Founded | 2001 older | 2017 |
| Headquarters | ||
| Headquarters | Westlake Village, United States | Oxford, United Kingdom |
| Employees | ||
| Employees | 34 | 31 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Series Unknown |
| Total Funding | ||
| Total Funding | $98.98M | $50.40M |
| Funding Rounds | ||
| Funding Rounds | 5 | 4 |
| Services | ||
| Services | Development of oncolytic immunotherapy, Clinical trial management, Expanded access programs | Not tracked yet |
| Target Customers | ||
| Target Customers | Cancer patients, Healthcare professionals, Clinical researchers | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Oncolytic Immunotherapy, Solid Tumors, Cancer Treatment, Clinical-stage Biotech, Viral Therapy, Immunotherapies, Clinical Trials, Cancer Research, Cancer Therapy, Personalized Medicine | Oncolytic Viral Therapy, Phenotypic Screening Platform, Cancer Treatment, Adenoviral Therapy, Clinical Stage Biotechnology, Pipeline Development, Solid Tumors, Liquid Tumors, Virology, Partnerships, Intravenous Delivery, Patient Population, Disease Combat, Science Innovation |
| Website | ||
| Website | genelux.com | theolytics.com |
About Genelux
Genelux Corporation (NASDAQ: GNLX) is a late clinical-stage biotechnology firm founded in 2001 and based in the United States. The company operates at the forefront of the Biopharma, Biotechnology, and Health Care industries, focusing on oncolytic immunotherapy to improve patient outcomes in cases o...
About Theolytics
Theolytics, a biotechnology company based in the United Kingdom, is dedicated to transforming patients’ lives through world-leading science and a great team. Founded in 2017, Theolytics is at the forefront of oncolytic viral therapy, harnessing viruses to combat cancer. The company's phenotypic scre...
We will tell you when either one moves
BounceWatch watches Genelux and Theolytics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Genelux and Theolytics — by email.
Frequently Asked Questions
Compare Genelux with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Genelux on 2 Apr 2026, and Theolytics on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.